This is the authors' abstract. We don't add key points for this paper.
Compounds acting via the neurotensin receptor type 2 (NTS2) are known to be active in animal models of acute and chronic pain. To identify novel NTS2 selective analgesics, we searched for NTS2 selective nonpeptide compounds using a FLIPR assay and identified the title compound (NTRC-824, 5) that, to our knowledge, is the first nonpeptide that is selective for NTS2 versus NTS1 and behaves like the endogenous ligand neurotensin in the functional assay.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Thomas et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: